Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2011

01-02-2011 | Endocrine Tumors

Reply to “25-Hydroxyvitamin D Status Does Not Affect Intraoperative Parathyroid Hormone Dynamics in Patients With Primary Hyperparathyroidism,” by Agarwal et al.

Author: Joel T. Adler, MD

Published in: Annals of Surgical Oncology | Issue 2/2011

Login to get access

Excerpt

The average amount of total vitamin 25-hydroxyvitamin D was 19.3 ± 0.5 vs. 42.5 ± 1.1 ng/mL (P < 0.001, independent sample t-test). As we described in our article, this is a serum measurement performed by high-performance liquid chromatography. It can be difficult to find the next culprit gland; however, preoperative imaging is helpful, and radio-guided parathyroidectomy can also point toward the correct gland. …
Metadata
Title
Reply to “25-Hydroxyvitamin D Status Does Not Affect Intraoperative Parathyroid Hormone Dynamics in Patients With Primary Hyperparathyroidism,” by Agarwal et al.
Author
Joel T. Adler, MD
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1411-7

Other articles of this Issue 2/2011

Annals of Surgical Oncology 2/2011 Go to the issue

Gastrointestinal Oncology

Sentinel Node Biopsy in Squamous-Cell Carcinoma of the Anal Canal

Pancreatic Tumors

Standardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 Trial

Endocrine Tumors

Incidental Thyroid Carcinoma by FDG-PET/CT: A Study of Clinicopathological Characteristics

Bone and Soft Tissue Sarcomas

Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy

Bone and Soft Tissue Sarcomas

ILP and RT: The Study That Will Never Be

Breast Oncology

Analyzing the Risk of Recurrence after Mastectomy for DCIS: A New Use for the USC/Van Nuys Prognostic Index